Skip to main content

TV 2134 Pill - purple capsule/oblong, 16mm

Pill with imprint TV 2134 is Purple, Capsule/Oblong and has been identified as Minocycline Hydrochloride Extended-Release 65 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Minocycline is used in the treatment of Acne; Bacterial Infection; Bartonellosis; Actinomycosis; Bullous Pemphigoid and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 65 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TV 2134

Minocycline hydrochloride extended-release 65 mg TV 2134

Minocycline Hydrochloride Extended-Release

TV 2134
65 mg
16.00 mm
Prescription only
Drug Class
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
00093-2134 (Discontinued)
Inactive Ingredients
carnauba wax, silicon dioxide, hypromellose 2910 (6 mPa.s), lactose monohydrate, magnesium stearate, polyethylene glycol 3350, polyethylene glycol 4000, titanium dioxide, triacetin, D&C Red No. 27, aluminum oxide, FD&C Blue No. 2, indigotindisulfonate sodium, FD&C Red No. 40

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.